GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
GE HealthCare Technologies Dividend Announcement
• GE HealthCare Technologies announced a quarterly dividend of $0.04 per ordinary share which will be made payable on 2025-02-14. Ex dividend date: 2025-01-14
• GE HealthCare Technologies's trailing twelve-month (TTM) dividend yield is 0.18%
• GE HealthCare Technologies's payout ratio for the trailing twelve months (TTM) is 3.22%
GE HealthCare Technologies Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2025-01-14 | $0.04 | quarterly | 2025-02-14 |
2024-10-18 | $0.03 | quarterly | 2024-11-15 |
2024-07-19 | $0.03 | quarterly | 2024-08-15 |
2024-04-18 | $0.03 | quarterly | 2024-05-15 |
2024-04-15 | $0.03 | quarterly | 2024-05-15 |
2024-01-12 | $0.03 | quarterly | 2024-02-15 |
2023-10-19 | $0.03 | quarterly | 2023-11-15 |
2023-07-20 | $0.03 | quarterly | 2023-08-15 |
2023-05-22 | $0.03 | quarterly | 2023-06-15 |
GE HealthCare Technologies Dividend per year
GE HealthCare Technologies Dividend growth
GE HealthCare Technologies Dividend Yield
GE HealthCare Technologies current trailing twelve-month (TTM) dividend yield is 0.18%. Interested in purchasing GE HealthCare Technologies stock? Use our calculator to estimate your expected dividend yield:
GE HealthCare Technologies Financial Ratios
GE HealthCare Technologies Dividend FAQ
Other factors to consider when evaluating GE HealthCare Technologies as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy GE HealthCare Technologies stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: GE HealthCare Technologies's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, GE HealthCare Technologies publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, GE HealthCare Technologies distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from GE HealthCare Technologies are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: GE HealthCare Technologies sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, GE HealthCare Technologies distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: GE HealthCare Technologies declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of GE HealthCare Technologies's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review GE HealthCare Technologies's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.